Biogen Inc.

NasdaqGS:BIIB

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

Location

United States

Market Cap

USD 20.36 B

Share Price

USD 138.86

Avg Daily Volume

1,431,362

Change (1 day)

2.17%

Change (1 year)

-32.61%

Change (YTD)

-9.19%

Biogen Inc. EBT Margin for the Trailing 12 Months (TTM) ending June 30, 2025: 17.98%

Biogen Inc. EBT Margin is 17.98% for the Trailing 12 Months (TTM) ending June 30, 2025, a 32.37% change year over year. EBT Ratio (Earnings Before Tax Ratio) is the fraction of earnings before taxes to total revenue, indicating the company's profitability before the impact of tax expenses.

Biogen Inc. EBT Margin for the Trailing 12 Months (TTM) ending June 30, 2024 was 13.58%, a -56.60% change year over year.
Biogen Inc. EBT Margin for the Trailing 12 Months (TTM) ending June 30, 2023 was 31.30%, a 43.91% change year over year.
Biogen Inc. EBT Margin for the Trailing 12 Months (TTM) ending June 30, 2022 was 21.75%, a 7.83% change year over year.
Biogen Inc. EBT Margin for the Trailing 12 Months (TTM) ending June 30, 2021 was 20.17%, a -59.66% change year over year.